[HTML][HTML] The tumor microenvironment of epithelial ovarian cancer and its influence on response to immunotherapy
GM Rodriguez, KJC Galpin, CW McCloskey… - Cancers, 2018 - mdpi.com
Immunotherapy as a treatment for cancer is a growing field of endeavor but reports of
success have been limited for epithelial ovarian cancer. Overcoming the challenges to …
success have been limited for epithelial ovarian cancer. Overcoming the challenges to …
[HTML][HTML] Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
DS Hong, BA Van Tine, S Biswas, C McAlpine… - Nature medicine, 2023 - nature.com
Affinity-optimized T cell receptors can enhance the potency of adoptive T cell therapy.
Afamitresgene autoleucel (afami-cel) is a human leukocyte antigen-restricted autologous T …
Afamitresgene autoleucel (afami-cel) is a human leukocyte antigen-restricted autologous T …
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
O Gordeeva - Seminars in cancer biology, 2018 - Elsevier
Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
A comprehensive guide to the MAGE family of ubiquitin ligases
AK Lee, PR Potts - Journal of molecular biology, 2017 - Elsevier
Melanoma antigen (MAGE) genes are conserved in all eukaryotes and encode for proteins
sharing a common MAGE homology domain. Although only a single MAGE gene exists in …
sharing a common MAGE homology domain. Although only a single MAGE gene exists in …
A photonic platform for donor spin qubits in silicon
Donor spins in silicon are highly competitive qubits for upcoming quantum technologies,
offering complementary metal-oxide semiconductor compatibility, coherence (T 2) times of …
offering complementary metal-oxide semiconductor compatibility, coherence (T 2) times of …
[HTML][HTML] Overexpression of MAGE-A9 is predictive of poor prognosis in epithelial ovarian cancer
Y Xu, C Wang, Y Zhang, L Jia, J Huang - Scientific reports, 2015 - nature.com
The cancer testis antigen, melanoma-associated antigen A9 (MAGE-A9), is expressed in
many kinds of different human cancers and is an important target for immunotherapy …
many kinds of different human cancers and is an important target for immunotherapy …
[HTML][HTML] The Melanoma-Associated Antigen Family A (MAGE-A): A promising target for cancer immunotherapy?
A Alsalloum, JA Shevchenko, S Sennikov - Cancers, 2023 - mdpi.com
Simple Summary Given that selecting an appropriate target is the first step in developing
effective cancer immunotherapy, we focus on melanoma-associated antigens (MAGEs) …
effective cancer immunotherapy, we focus on melanoma-associated antigens (MAGEs) …
[HTML][HTML] MAGE-A antigens and cancer immunotherapy
P Zajac, E Schultz-Thater, L Tornillo, C Sadowski… - Frontiers in …, 2017 - frontiersin.org
MAGE-A antigens are expressed in a variety of cancers of diverse histological origin and
germinal cells. Due to their relatively high tumor specificity, they represent attractive targets …
germinal cells. Due to their relatively high tumor specificity, they represent attractive targets …
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
JP Sanderson, DJ Crowley, GE Wiedermann… - …, 2020 - Taylor & Francis
ABSTRACT A substantial obstacle to the success of adoptive T cell-based cancer
immunotherapy is the sub-optimal affinity of T-cell receptors (TCRs) for most tumor antigens …
immunotherapy is the sub-optimal affinity of T-cell receptors (TCRs) for most tumor antigens …